Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 9:38 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1849–1872 of 21,991 matching trials from the live ClinicalTrials.gov search.

Filters: Recruiting Clear all

Conditions: Opioid Abuse (Disorder), Stimulant Use Disorders
Interventions: Patient Navigation; Behavioral
Lead sponsor: University of Utah; Other
Eligibility: 18 Years and older · Female only
Enrollment: 429 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Hodgkin Lymphoma, Relapsed or Refractory Hodgkin Lymphoma
Interventions: pembrolizumab, gemcitabine, vinorelbine, liposomal doxorubicin, Stem cell mobilization and collection, Involved-site radiation therapy; Drug · Procedure · Radiation
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 257 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2027
U.S. locations: 10
States / cities: Duarte, California • Stanford, California • Miami, Florida + 7 more

Conditions: Anal Squamous Cell Carcinoma
Interventions: Artificial Intelligence Guided Daily Radiotherapy Treatment Planning and Delivery, Mitomycin-C, 5-Fluorouracil, Capecitabine; Radiation · Drug
Lead sponsor: Columbia University; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2028
U.S. locations: 1
States / cities: New York, New York

Conditions: Squamous Non-small Cell Lung Cancer
Interventions: Intismeran Autogene, Pembrolizumab, Carboplatin, Paclitaxel, Nab-paclitaxel, Placebo; Biological · Drug · Other
Lead sponsor: Merck Sharp & Dohme LLC; Industry
Eligibility: 18 Years and older
Enrollment: 180 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2031
U.S. locations: 11
States / cities: Tampa, Florida • Ann Arbor, Michigan • St Louis, Missouri + 8 more

Conditions: Cardiometabolic Health Indicators
Interventions: Recreation Enhancement; Behavioral
Lead sponsor: Rush University Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 120 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Dietary Habits
Interventions: Day shift protocol - Diet order A-B, Day shift protocol - Diet order B-A, Night shift protocol - Diet order A-B, Night shift protocol - Diet order B-A; Behavioral
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years to 45 Years
Enrollment: 48 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Bone Marrow Transplant, Stem Cell Transplant
Interventions: Zoster Vaccine Recombinant; Drug
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years to 79 Years
Enrollment: 55 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2030
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Cannabis Intoxication
Interventions: Cannabis, Pregnenolone 250 mg, Pregnenolone 500 mg, Placebo, Placebo brownie; Drug
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Immune Checkpoint Therapy
Interventions: Troponin surveillance, Standard of care; Diagnostic Test · Other
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 980 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Cardiac Arrest (CA)
Interventions: Not listed
Lead sponsor: Children's Hospital of Philadelphia; Other
Eligibility: 37 Weeks to 18 Years
Enrollment: 1,620 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2029
U.S. locations: 22
States / cities: Orange, California • Stanford, California • Denver, Colorado + 18 more

Conditions: Heart Failure, Heart Failure - NYHA II - IV
Interventions: FibroScan, Right-sided Heart Catheterization, Transthoracic echocardiography, Blood Sample Analysis; Device · Procedure · Biological
Lead sponsor: Echosens; Industry
Eligibility: 18 Years and older
Enrollment: 149 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 4
States / cities: Los Angeles, California • Minneota, Minnesota • Charleston, South Carolina + 1 more

Conditions: Deafness
Interventions: Electrode-Neural Interface; Device
Lead sponsor: NYU Langone Health; Other
Eligibility: 2 Years to 90 Years
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2027
U.S. locations: 1
States / cities: New York, New York

Conditions: Post Stroke, Post Stroke Hand Rehabilitation
Interventions: Portable Rehabilitation Interface (PoRI); Device
Lead sponsor: Yale University; Other
Eligibility: 18 Years and older
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Milford, Connecticut

Conditions: Abdominal Wall Hernia
Interventions: Preoperative Weight Management Program; Other
Lead sponsor: Benjamin T. Miller; Other
Eligibility: 18 Years and older
Enrollment: 258 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2027
U.S. locations: 2
States / cities: Chicago, Illinois • Cleveland, Ohio

Conditions: Low Vision Aids
Interventions: At Home Use; Device
Lead sponsor: Brooks Rehabilitation; Other
Eligibility: 18 Years to 90 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Jacksonville, Florida

Conditions: Sleep, Sleep Quality
Interventions: Novel powdered sleep supplement, Placebo; Dietary Supplement
Lead sponsor: Athletic Greens International; Industry
Eligibility: 35 Years to 65 Years
Enrollment: 140 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026
U.S. locations: 1
States / cities: Santa Monica, California

Conditions: Microbiota, Gut Microbiome, Eczema, Microbiome
Interventions: Tailored Recommendations, Consult Call, Educational Email Series; Dietary Supplement · Behavioral
Lead sponsor: Seeding Inc; Industry
Eligibility: 0 Months to 3 Months
Enrollment: 250 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Austin, Texas

Conditions: Parkinson Disease
Interventions: HBI-002, Vehicle (placebo); Drug
Lead sponsor: Hillhurst Biopharmaceuticals, Inc.; Industry
Eligibility: 40 Years to 80 Years
Enrollment: 36 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 8
States / cities: Fountain Valley, California • Gainesville, Florida • Boston, Massachusetts + 5 more

Conditions: Heart Failure
Interventions: GWTG Heart Failure program; Other
Lead sponsor: American Heart Association; Other
Eligibility: 18 Years to 125 Years
Enrollment: 128,026 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2005 – 2040
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Healthy Volunteer, Bone Alteration, Bone and Joint Cancer, Bone and Joint Infection, Arthritis
Interventions: 18F-NaF; Drug
Lead sponsor: Akiva Mintz; Other
Eligibility: 18 Years to 120 Years
Enrollment: 200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2030
U.S. locations: 1
States / cities: Englewood, New Jersey

Conditions: EGFR Inhibitor-associated Rash
Interventions: ATR04-484, Vehicle; Drug
Lead sponsor: Azitra Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 6
States / cities: Hot Springs, Arkansas • New Haven, Connecticut • New York, New York + 3 more

Conditions: Host Defense Mechanisms
Interventions: Not listed
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 18 Years to 120 Years
Enrollment: 200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: Started 2001
U.S. locations: 1
States / cities: Hamilton, Montana

Conditions: Multiple Myeloma
Interventions: Sirolimus, Teclistamab, Talquetamb; Drug · Biological
Lead sponsor: Christopher Strouse; Other
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: Acute Ischemic Stroke
Interventions: Mechanical Thrombectomy; Device
Lead sponsor: Medtronic Neurovascular Clinical Affairs; Industry
Eligibility: 18 Years and older
Enrollment: 1,500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2031
U.S. locations: 3
States / cities: Flint, Michigan • Buffalo, New York • Houston, Texas

Search by objective public record fields.

Optimizing Pregnancy and Treatment Interventions for Moms 3.0

Phase II Study of Second- Line Pembrolizumab Plus GVD for Relapsed or Refractory Hodgkin Lymphoma

Adaptive Radiation in Anal Cancer

A Study of Intismeran Autogene (V940)/Placebo + Pembrolizumab and Chemotherapy in Metastatic Squamous Non-Small Cell Lung Cancer (V940-013)

Behavioral Economic Attributes of Recreation

Can Food Timing Reduce Your Diabetes Risk?

Shingrix In Recipients of Allogeneic Transplants

Pregnenolone as a Treatment for Cannabis Intoxication

STRICT - Surveillance With TRoponin During Immune Checkpoint Therapy

Physiology-directed Epinephrine Dosing in Pediatric Cardiac Arrest

Evaluation of Liver Stiffness Performance, by FibroScan®, to Detect Elevated Central Venous Pressure (CVP)

Investigating Auditory Processing in the Users of Auditory Brainstem and Cochlear Implants

PoRI Clinical Trial

Preoperative Weight Loss for Open Abdominal Wall Reconstruction

Assessing the Impact of eSight Go At-Home Usage in Individuals With Visual Impairment

The Effects of a Nutritional Supplement on Sleep Quality

Flourish: Exploring the Early Infant Gut Microbiome

Low-dose Carbon Monoxide (HBI-002) Trial to Evaluate Safety, Tolerability, PK, and Biomarkers in Parkinson's Disease

Get With The Guidelines-Heart Failure Registry

Ultralow Dose PET Imaging for 18F-NaF Uptake

A Study to Evaluate Topical ATR04-484 for EGFRi-Associated Dermal Toxicity

Molecular Basis of Human Phagocyte Interactions With Bacterial Pathogens

Sirolimus Pre-conditioning on T Cell Activity and T-cell Engaging Bispecific Antibody Efficacy in Multiple Myeloma

REal-world Clinical evAulation of Medtronic NeurOVascular Products for Acute Ischemic Stroke (RECANOVA Registry)